MLchartDataset catalogue

Zydelig

Term · Oncology and biomedicine · MLC-T-ONC-009502

A drug used with rituximab to treat chronic lymphocytic leukemia that has come back. It is also being studied in the treatment of other types of cancer. Zydelig blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of kinase inhibitor. Also called idelalisib.

Table 1. Record
IdentifierMLC-T-ONC-009502
FieldOncology and biomedicine
Synonymsidelalisib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-009502",
  "term": "Zydelig",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with rituximab to treat chronic lymphocytic leukemia that has come back. It is also being studied in the treatment of other types of cancer. Zydelig blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of kinase inhibitor. Also called idelalisib.",
  "synonyms": [
    "idelalisib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/zydelig/"
}

Record 17,709 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.